Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (441-450 of 652) with videos related to

Pageof 66
Sort By:
The American Journal of Gastroenterology|October 22, 2014
Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studiesAlexandra D Frolkis, Debra S Lipton, Kirsten M Fiest, et al.
Gut|February 20, 2016
The safety of vedolizumab for ulcerative colitis and Crohn's diseaseJean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, et al.
The American Journal of Gastroenterology|August 3, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's DiseaseStephan R Targan, Brian Feagan, Severine Vermeire, et al.
Advances in Therapy|July 11, 2025
Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn's Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) SurveyDavid T Rubin, Alison Potts Bleakman, Simon Travis, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 1, 2021
Quantitative Ultrafast Electron-Temperature Dynamics in Photo-Excited Au NanoparticlesMaria Sygletou, Stefania Benedetti, Marzia Ferrera, et al.
Journal of Crohn'S & Colitis|November 12, 2023
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b StudyBram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Journal of Crohn'S & Colitis|April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspectivePavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Frontiers in Nutrition|March 10, 2023
Nutritional interventions in adult fibrostenotic Crohn's disease: A systematic reviewJared L Cooper, Ryan E Rosentreter, Alexis Filyk, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Pageof 66

Showing results (441-450 of 652) with videos related to

Sort By:
Pageof 66
The American Journal of Gastroenterology|October 22, 2014
Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studiesAlexandra D Frolkis, Debra S Lipton, Kirsten M Fiest, et al.
Gut|February 20, 2016
The safety of vedolizumab for ulcerative colitis and Crohn's diseaseJean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, et al.
The American Journal of Gastroenterology|August 3, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's DiseaseStephan R Targan, Brian Feagan, Severine Vermeire, et al.
Advances in Therapy|July 11, 2025
Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn's Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) SurveyDavid T Rubin, Alison Potts Bleakman, Simon Travis, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 1, 2021
Quantitative Ultrafast Electron-Temperature Dynamics in Photo-Excited Au NanoparticlesMaria Sygletou, Stefania Benedetti, Marzia Ferrera, et al.
Journal of Crohn'S & Colitis|November 12, 2023
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b StudyBram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Journal of Crohn'S & Colitis|April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspectivePavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Frontiers in Nutrition|March 10, 2023
Nutritional interventions in adult fibrostenotic Crohn's disease: A systematic reviewJared L Cooper, Ryan E Rosentreter, Alexis Filyk, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Pageof 66